Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Generation of two induced pluripotent stem cell lines from catecholaminergic polymorphic ventricular tachycardia patients carrying RYR2 mutations

Stem Cell Research(2023)10.1016/j.scr.2023.103111Source: DataRank Database

Generation of two induced pluripotent stem cell lines from catecholaminergic polymorphic ventricular tachycardia patients carrying RYR2 mutations is a research paper published in Stem Cell Research (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

hPSCreg

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.70)OA: goldTopics (37)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Nadjet Belbachir,Wenshu Zeng ORCID,Christopher D Yan,Sai Navada,Marco Pérez ORCID

Live enrichment

PubMed:37210947 PMC:PMC11059235 OpenAlex:https://openalex.org/W4377220751

National Institutes of Health

Grant: 18CVD05

National Institutes of Health

Grant: 75N92020D00019

National Institutes of Health

Grant: R01 HL113006

National Institutes of Health

Grant: R01 HL141371

National Institutes of Health

Grant: R01 HL141851

Foundation for the National Institutes of Health

Leducq Foundation

FWCI

0.70

Citation Percentile

0.7%

Citation Trend

2023

2024

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.scr.2023.103111

publisherhttps://doi.org/10.1016/j.scr.2023.103111

publisherhttps://api.elsevier.com/content/article/PII:S1873506123000971?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1873506123000971?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37210947

Fields of Study

Cardiac electrophysiology and arrhythmiasIon channel regulation and functionCardiac Arrhythmias and TreatmentsHumansInduced Pluripotent Stem CellsRyanodine Receptor Calcium Release ChannelTachycardia, VentricularMutationArrhythmias, CardiacPolymorphic Catecholaminergic Ventricular Tachycardia

MeSH Terms

Polymorphic Catecholaminergic Ventricular TachycardiaArrhythmias, CardiacHumansMutationTachycardia, VentricularRyanodine Receptor Calcium Release ChannelInduced Pluripotent Stem Cells

Keywords

Ryanodine receptor 2Catecholaminergic polymorphic ventricular tachycardiaBiologyInduced pluripotent stem cellRyanodine receptorMissense mutationCatecholaminergicInternal medicineCell biologyPhenotypeGeneticsEndocrinologyGeneReceptorCatecholamineEmbryonic stem cellMedicineHuman Induced Pluripotent Stem CellsCatecholaminergic Polymorphic Ventricular Tachycardia (Cpvt)Ryanodine Receptor 2 (Ryr2)

Sustainable Development Goals

SDG 0: Good health and well-being

Generation of two induced pluripotent stem cell lines from catecholaminergic polymorphic ventricular tachycardia patients carrying RYR2 mutations

FAIR Checklist

Authors (7)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)